QR-Code

Efficacy and safety of different proprotein convertase subtilisin/kexin type 9 inhibitors in the general population and solid organ transplant recipients: a network meta-analysis

IntroductionWe conducted a network meta-analysis (NMA) to compare the efficacy (primarily assessed by low-density lipoprotein cholesterol (LDL-C) reduction and cardiovascular event (CVE) incidence) and safety (total adverse events (AEs), neurocognitive events (NCEs), injection site reactions, infect...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Bohan Luo, Zhuang Sun, Han Luo
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2025-08-01
Schriftenreihe:Frontiers in Pharmacology
Schlagworte:
PCSK9 inhibitors
clinical efficacy
adverse reactions
mortality
meta-analysis
Online-Zugang:https://www.frontiersin.org/articles/10.3389/fphar.2025.1584612/full
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge